The Healthcare Policy Podcast ® Produced by David Introcaso
Aug 2, 2026 · 34 min · 11 segments
As everyone is well aware, healthcare, particularly acute care (think: hospitals) has become increasingly more unaffordable. For the four-year period ending next year ERISA or employer-sponsored…
Briefly on background, over the past few years, commercial medical insurance has become increasingly unaffordable.
By the end of this year, 6 million or 23% of ACA marketplace beneficiaries are expected to lose coverage.
And a recent West Health survey found less than half of Americans have the ability to pay for needed medical visits and prescriptions.
Over the past decade, federal policymakers have decided price transparency is largely the answer.
Per Ken Arrow, medical care is likely not a shoppable commercial market product.
as Gerald Anderson famously argued in his 03 article titled, It's the Price is Stupid, focusing on price ignores or excuses the fact that in a functioning market, price is largely determined by underlying cost, and here costs are largely ignored even though hospital prices are poorly and unpredictably correlated to prices.
In recent pricey research published in, for example, the New England Journal of Health Affairs, and by Georgetown Center for Health Insurance Research has not shown much success.
With me again to discuss price transparency is Turquoise Health's Ms. Carol Skenes.
Briefly on background, over the past few years, commercial medical insurance has become increasingly unaffordable.
By the end of this year, 6 million or 23% of ACA marketplace beneficiaries are expected to lose coverage.
And a recent West Health survey found less than half of Americans have the ability to pay for needed medical visits and prescriptions.
Over the past decade, federal policymakers have decided price transparency is largely the answer.
Per Ken Arrow, medical care is likely not a shoppable commercial market product.
as Gerald Anderson famously argued in his 03 article titled, It's the Price is Stupid, focusing on price ignores or excuses the fact that in a functioning market, price is largely determined by underlying cost, and here costs are largely ignored even though hospital prices are poorly and unpredictably correlated to prices.
In recent pricey research published in, for example, the New England Journal of Health Affairs, and by Georgetown Center for Health Insurance Research has not shown much success.
With me again to discuss price transparency is Turquoise Health's Ms. Carol Skenes.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.